Premium
Bill to deregulate buprenorphine raises concerns among OTPs
Author(s) -
Knopf Alison
Publication year - 2019
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32510
Subject(s) - buprenorphine , methadone , narcotic antagonists , opioid use disorder , medicine , opioid , addiction , psychiatry , (+) naloxone , receptor
The Mainstreaming Addiction Treatment Act (H.R. 2482) would deregulate buprenorphine. Adminstration of the medication is held to high standards when used in the treatment of opioid use disorder, like methadone. Also like methadone, those standards don't apply when the medication is used to treat pain. The bill only applies to buprenorphine.